Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-848-3 | CAS number: 75-20-7
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1999
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Bioavailability, biodistribution and toxicity of biocal a new calcium source. Comparative studies in rats
- Author:
- Sarabia, MI, et al.
- Year:
- 1 999
- Bibliographic source:
- Nutr Res 19: 1223–1231
Materials and methods
- Objective of study:
- absorption
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Application of 30 mg Ca/kg bw/d (45Ca-Gluconate) by gavage, for 12 days
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Calcium gluconate
- EC Number:
- 206-075-8
- EC Name:
- Calcium gluconate
- Cas Number:
- 299-28-5
- Molecular formula:
- C6H12O7.1/2Ca
- IUPAC Name:
- calcium bis(2,3,4,5,6-pentahydroxyhexanoate) (non-preferred name)
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- 45 Ca
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Duration and frequency of treatment / exposure:
- 12 days; daily
Doses / concentrations
- Dose / conc.:
- 30 mg/kg bw/day (nominal)
- No. of animals per sex per dose / concentration:
- no data
- Control animals:
- not specified
Results and discussion
Main ADME results
- Type:
- absorption
- Results:
- 99%
Toxicokinetic / pharmacokinetic studies
Transfer into organs
- Key result
- Test no.:
- #1
- Transfer type:
- other: transfer to bones
- Observation:
- distinct transfer
- Remarks:
- bones
- Details on excretion:
- 1.2 % Ca was excreted in urin
Applicant's summary and conclusion
- Conclusions:
- Ca2+ applied by gavage is almost completely resorbed and built into the bones. 1.2 % of the dose was excreted in urine
- Executive summary:
In a metabolism study, 45-Calcium bis(2,3,4,5,6)-pentahydroxyhexanoate was administered to rats daily by oral gavage at a dose level of 30 mg/kg bw/day for 12 days.
The test material was almost completely resorbed and built into the bones. 1.2 % of the dose was excreted in urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
